Zobrazeno 1 - 10
of 240
pro vyhledávání: '"AH Schmaier"'
Publikováno v:
Blood. 75:2401-2407
C1 inhibitor (C1 INH) is the major protease inhibitor of the first components of the classic complement system and of the proteases of the Hageman factor pathways. Since C1 INH may modulate inflammatory reactions associated with complement and contac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6814c542b1f81a3fa67bbff76f713b8f
https://doi.org/10.1182/blood.v75.12.2401.bloodjournal75122401
https://doi.org/10.1182/blood.v75.12.2401.bloodjournal75122401
Publikováno v:
Blood. 82(2)
Human platelets contain a pool of C1 inhibitor (C1 INH) distinct from that in plasma. Twelve normal platelet samples washed by centrifugation had a mean platelet C1 INH antigen level of 19.3 +/- 2.8 ng (mean +/- SEM) per 10(8) platelets. These values
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7506a1ab43479eda06a43f67ced8f9c6
https://pubmed.ncbi.nlm.nih.gov/8329703
https://pubmed.ncbi.nlm.nih.gov/8329703
Publikováno v:
Blood. 81(11)
The vasoactive compound bradykinin (BK) is liberated by proteolytic cleavage from high molecular weight kininogen (HK) and low molecular weight kininogen (LK). Expression of kininogens on cell surface receptors may affect the delivery of BK at sites
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9b81fa04439601bfa9202bd069aecb
https://pubmed.ncbi.nlm.nih.gov/8388750
https://pubmed.ncbi.nlm.nih.gov/8388750
Publikováno v:
Blood. 56(6)
After being envenomated by the timber rattlesnake, a patient was found to have a platelet count of 5000 per microliter, prothrombin time and activated partial thromboplastin time both greater than 150 sec, plasma fibrinogen 0 mg/dl, and fibrinogen sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13bc3442936eb982bbb310304497301
https://pubmed.ncbi.nlm.nih.gov/7437509
https://pubmed.ncbi.nlm.nih.gov/7437509
Publikováno v:
Blood. 67(1)
High mol wt kininogen (HMWK), the major cofactor-substrate of the contact phase of coagulation, is contained within and secreted by platelets. Studies have been performed to localize platelet HMWK in both the unstimulated and activated platelet and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80954c7f0aba44079fbf38d26bcb8c3f
https://pubmed.ncbi.nlm.nih.gov/3000474
https://pubmed.ncbi.nlm.nih.gov/3000474
Publikováno v:
Blood. 59(6)
Washed platelets, contaminated with less than 0.20% plasma factor XI, were examined for the presence of factor XI antigen and activity. These platelets contained a factor-XI-like coagulant activity (0.67 +/- 0.11 U/10(11) platelets) that remained con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a38eefbb781df06257d11921c4c2b7b5
https://pubmed.ncbi.nlm.nih.gov/7044446
https://pubmed.ncbi.nlm.nih.gov/7044446
Autor:
AH Schmaier, RW Colman
Publikováno v:
Blood. 56(6)
Crotalocytin, a platelet activating protein from timber rattlesnake venom, was studied to characterize its nature and to investigate its action on platelets. It exhibited proteolytic activity on the substrate azocoll and amidolytic activity on severa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a29a40d39fac60a0b1ef7a983be7472
https://pubmed.ncbi.nlm.nih.gov/6254583
https://pubmed.ncbi.nlm.nih.gov/6254583
Autor:
Ah, Schmaier, Cicardi M, Reshef A, Moldovan D, Mócsai A, López-Trascasa M, Al, Lera, Nj, Brown, Ae, Germenis, Filippelli-Silva R, Da, Duarte, Rp, Martin, Az, Sin
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::364d18db6e2d8a5788fe9741fb1aefc3
http://europepmc.org/abstract/PMC/PMC5496025
http://europepmc.org/abstract/PMC/PMC5496025
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lira AL; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR. Electronic address: dasilva@ohsu.edu., Taskin B; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR., Puy C; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR., Keshari RS; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK., Silasi R; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK., Pang J; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR., Aslan JE; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR., Shatzel JJ; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR; Division of Hematology and Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR., Lorentz CU; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR; Aronora, Inc, Portland, OR., Tucker EI; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR; Aronora, Inc, Portland, OR., Schmaier AH; Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH., Gailani D; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Lupu F; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK., McCarty OJT; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Dec 18, pp. 108110. Date of Electronic Publication: 2024 Dec 18.